Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene
- PMID: 9541104
- PMCID: PMC1051243
- DOI: 10.1136/jmg.35.3.205
Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene
Erratum in
- J Med Genet 1998 Jun;35(6):528
Abstract
DNA studies in familial hypertrophic cardiomyopathy (FHC) have shown that it is caused by mutations in genes coding for proteins which make up the muscle sarcomere. The majority of mutations in the FHC genes result from missense changes, although one of the most recent genes to be identified (cardiac myosin binding protein C gene, MYBPC3) has predominantly DNA mutations which produce truncated proteins. Both dominant negative and haploinsufficiency models have been proposed to explain the molecular changes in FHC. This study describes two Australian families with FHC caused by different mutations in MYBPC3. The first produces a de novo Asn755Lys change in a cardiac specific domain of MYBPC3. The second is a Gln969X nonsense mutation which results in a truncated protein. Neither mutation has previously been found in the MYBPC3 gene. The consequences of DNA changes on the function of cardiac myosin binding protein C are discussed in relation to current molecular models for this disorder.
Similar articles
-
Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.Circ Res. 1997 Mar;80(3):427-34. Circ Res. 1997. PMID: 9048664
-
Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.N Engl J Med. 1998 Apr 30;338(18):1248-57. doi: 10.1056/NEJM199804303381802. N Engl J Med. 1998. PMID: 9562578
-
Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.J Med Genet. 1999 Jul;36(7):542-5. J Med Genet. 1999. PMID: 10424815 Free PMC article.
-
Mutations in cardiac myosin heavy chain genes cause familial hypertrophic cardiomyopathy.Mol Biol Med. 1991 Apr;8(2):159-66. Mol Biol Med. 1991. PMID: 1806760 Review.
-
Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.Pflugers Arch. 2019 May;471(5):781-793. doi: 10.1007/s00424-018-2226-9. Epub 2018 Nov 20. Pflugers Arch. 2019. PMID: 30456444 Free PMC article. Review.
Cited by
-
Modeling complex genetic interactions in a simple eukaryotic genome: actin displays a rich spectrum of complex haploinsufficiencies.Genes Dev. 2007 Jan 15;21(2):148-59. doi: 10.1101/gad.1477507. Epub 2006 Dec 13. Genes Dev. 2007. PMID: 17167106 Free PMC article.
-
The genomics of cardiovascular disorders: therapeutic implications.Drugs. 2000 May;59(5):1025-42. doi: 10.2165/00003495-200059050-00001. Drugs. 2000. PMID: 10852637 Review.
-
The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.Cardiovasc Res. 2010 Jan 15;85(2):330-8. doi: 10.1093/cvr/cvp247. Epub 2009 Jul 17. Cardiovasc Res. 2010. PMID: 19617224 Free PMC article. Review.
-
Counselling issues in familial hypertrophic cardiomyopathy.J Med Genet. 1998 Mar;35(3):183-8. doi: 10.1136/jmg.35.3.183. J Med Genet. 1998. PMID: 9541100 Free PMC article.
-
A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.J Clin Invest. 1998 Oct 1;102(7):1292-300. doi: 10.1172/JCI3880. J Clin Invest. 1998. PMID: 9769321 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases